Novartis Oncology Corporate Counsel Salary | Comparably
At Novartis Oncology, we are passionate about the discovery and development of innovative medicines. read more
EMPLOYEE
PARTICIPANTS
14
TOTAL
RATINGS
161

Novartis Oncology Corporate Counsel Salary

The average Novartis Oncology Corporate Counsel earns an estimated $202,656 annually, which includes an estimated base salary of $171,256 with a $31,400 bonus. Novartis Oncology's Corporate Counsel compensation is $24,312 more than the US average for a Corporate Counsel. Corporate Counsel salaries at Novartis Oncology can range from $93,000 - $320,000.

The Legal Department at Novartis Oncology earns $7,169 more on average than the Marketing Department.

Last updated 3 years ago.

$42k
$90k
$131k
$175k
$320k
$500k
$590k
$202,656
Average Compensation
$171,256
avg. base
$31,400
avg. bonus

Corporate Counsel Salaries at Novartis Oncology

Corporate Counsels earn $4,595 more than Corporate Counsels, and $3,681 less than General Counsels.

General Counsel
$206k*
Corporate Counsel
$198k*
Contracts Specialist
$119k*
Paralegal
$70k*
* estimated salary

Compensation at Novartis Oncology by Department

The Legal Department averages $7,169 more than the Marketing Department, and $7,269 less than the HR Department

HR
$109,931 Avg. total comp.
+$7k
Legal
$102,662 Avg. total comp.
Marketing
$95,493 Avg. total comp.
-$7k

Corporate Counsel Compensation by Gender (All Companies)

The average female Corporate Counsel at companies similar size to Novartis Oncology reported making $190,419, while the average male Corporate Counsel at similar sized companies reported making $218,835.

Corporate Counsel Compensation by Ethnicity (All Companies)

The average Caucasian Corporate Counsel at companies similar size to Novartis Oncology reported making $215,700, while the average Asian or Pacific Islander Corporate Counsel at similar sized companies reported making $176,738.

How Corporate Counsels at Novartis Oncology Rate Their Compensation

The majority of Corporate Counsels at Novartis Oncology believe they're not compensated fairly. 100% of Corporate Counsels at Novartis Oncology say they receive annual bonuses, and the vast majority (83%) are satisfied with their benefits. See more compensation ratings at Novartis Oncology

×
Rate your company